Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2003

Content (16 Articles)

A Novel Approach of Targeted Ablation of Mammary Carcinoma Cells Through Luteinizing Hormone Receptors using Hecate-CGβ Conjugate

Gabriel Bodek, Nafis Ahmed Rahman, Monika Zaleska, Rabah Soliymani, Hikka Lankinen, William Hansel, Ilpo Huhtaniemi, Adam J. Ziecik

Enterolactone in Breast Cyst Fluid: Correlation with EGF and Breast Cancer Risk

Francesco Boccardo, Gian Luigi Lunardi, Anna Rita Petti, Alessandra Rubagotti

Differential Effects of Raloxifene, Tamoxifen and Fulvestrant on a Murine Mammary Carcinoma

Caroline A. Lamb, Luisa A. Helguero, Victoria Fabris, Lucas Colombo, Alfredo A. Molinolo, Claudia Lanari

Comparison of p53 Mutational Status with mRNA and Protein Expression in a Panel of 24 Human Breast Carcinoma Cell Lines

Nicole Concin, Christa Zeillinger, Dan Tong, Margit Stimpfl, Margit König, Dieter Printz, Felix Stonek, Christian Schneeberger, Lukas Hefler, Christian Kainz, Sepp Leodolter, Oskar A. Haas, Robert Zeillinger

Axilla Surgery Severely Affects Quality of Life: Results of a 5-Year Prospective Study in Breast Cancer Patients

Jutta Engel, Jacqueline Kerr, Anne Schlesinger-Raab, Hansjörg Sauer, Dieter Hölzel

hOGG1 Ser 326 Cys Polymorphism and Breast Cancer Risk among Asian Women

Ji-Yeob Choi, Nobuyuki Hamajima, Kazuo Tajima, Keun-Young Yoo, Kyung-Sik Yoon, Sue Kyung Park, Sook-Un Kim, Kyung-Mu Lee, Dong-Young Noh, Se-Hyun Ahn, Kuk-Jin Choe, Wonshik Han, Ari Hirvonen, Daehee Kang

PPARγ Ligands and ATRA Inhibit the Invasion of Human Breast Cancer Cells in vitro

H. Liu, C. Zang, M.H. Fenner, K. Possinger, E. Elstner

Expression Profiling of Breast Cancer Cells by Differential Peptide Display

Harald Tammen, Hans Kreipe, Rüdiger Hess, Markus Kellmann, Ulrich Lehmann, Andreas Pich, Norbert Lamping, Peter Schulz-Knappe, Hans-Dieter Zucht, Richard Lilischkis

Transformation of Non-Cancerous Human Breast Epithelial Cell Line MCF10A by the Tobacco-Specific Carcinogen NNK

Jianxun Mei, Hongbo Hu, Michael McEntee, Howard Plummer III, Ping Song, Hwa-Chain R. Wang

Localization of BRCA1 Protein in Human Breast Cancer Cells

Monique Chambon, Philippe Nirdé, Michel Gleizes, Pascal Roger, Françoise Vignon

Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors

Els M.J.J. Berns, Maaike J.M. Dirkzwager-Kiel, Vibeke Kuenen-Boumeester, Mieke Timmermans, Leon C. Verhoog, Ans M.W. van den Ouweland, Hanne Meijer-Heijboer, Jan G.M. Klijn, Theo H. van der Kwast

E1AF Expression Levels are not Associated with Prognosis in Human Breast Cancer

Paul N. Span, Peggy Manders, Joop J.T.M. Heuvel, Louk V.A.M. Beex, C.G.J. (Fred) Sweep

Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells

Partha P. Manna, Andrés Jaramillo, Kanchana Majumder, Lacey G. Campbell, Timothy P. Fleming, Jill R. Dietz, John F. Dipersio, T. Mohanakumar

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine